Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 M^pro: an in silico approach towards drug repurposing

References

• Abraham Peele, K., Chandrasai, P., Srihansa, T., Krupanidhi, T., Vijaya Sai, A., John Babu, D., Indira, M., Ranganadha, A. R., & Venkateswarulu, T. C. (2020). Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study. Informatics in Medicine Unlocked, 19, 100345. https://doi.org/10.1016/j.imu.2020.100345
   PubMedGoogle Scholar
• Adejoro, I., Babatunde, D., & Tolufashe, G. (2020). Molecular docking and dynamic simulations of some medicinal plants compounds against SARS-CoV-2: An in silico study. Journal of Taibah University for Science, 14(1), 1563–1570. https://doi.org/10.1080/16583655.2020.1848049
   Web of Science ®Google Scholar
• Ami, E., Nakahara, K., Sato, A., Nguyen, J.-T., Hidaka, K., Hamada, Y., Nakatani, S., Kimura, T., Hayashi, Y., & Kiso, Y. (2007). Synthesis and antiviral property of allophenylnorstatine-based HIV protease inhibitors incorporating d-cysteine derivatives as P2/P3 moieties. Bioorganic & Medicinal Chemistry Letters, 17(15), 4213–4217. https://doi.org/10.1016/j.bmcl.2007.05.039
   PubMed Web of Science ®Google Scholar
• Baldwin, E. T., Bhat, T. N., Gulnik, S., Liu, B., Topol, I. A., Kiso, Y., Mimoto, T., Mitsuya, H., & Erickson, J. W. (1995). Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine. Structure (London, England : 1993), 3(6), 581–590.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay, P., & Meher, BR. (2006). Drug resistance of HIV-1 protease against JE-2147: I47V mutation investigated by molecular dynamics simulation. Chemical Biology & Drug Design, 67(2), 155–161. https://doi.org/10.1111/j.1747-0285.2006.00348.x
   PubMed Web of Science ®Google Scholar
• Bayly, C. L., Cieplak, P., Cornell, W. D., & Kollman, P. A. (1993). A well-behaved electrostatic potential based method using charge restraints for determining atom-centered charges: The RESP model. Journal of Physical Chemistry, 97(1), 0269.
   Google Scholar
• Bello, M., Martínez-Muñoz, A., & Balbuena-Rebolledo, I. (2020). Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA. Journal of Molecular Modeling, 26, 340. https://doi.org/10.1007/s00894-020-04600-4
   PubMed Web of Science ®Google Scholar
• Berendsen, H., J. C., Postma, J. P. M., Van Gunsteren, W. F., Dinola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/10.1063/1.448118
   Web of Science ®Google Scholar
• Bhatnagar, T., Murhekar, M. V., Soneja, M., Gupta, N., Giri, S., Wig, N., & Gangakhedkar, R. (2020). Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use. Indian Journal of Medical Research, 151(2), 184–189. https://doi.org/10.4103/ijmr.IJMR_502_20
   PubMed Web of Science ®Google Scholar
• Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., Li, X., Xia, J., Chen, N., Xiang, J., Yu, T., Bai, T., Xie, X., Zhang, L., Li, C., … Wang, C. (2020). A trial of Lopinavir–Ritonavir in adults hospitalized with severe Covid-19. The New England Journal of Medicine, 382(19), 1787–1799. https://doi.org/10.1056/NEJMoa2001282
   PubMed Web of Science ®Google Scholar
• Case, D. A., Ben-Shalom, I.Y., Brozell, S.R., Cerutti, D.S., Cheatham, III, T.E., Cruzeiro, V.W.D., Darden, T.A., Duke, R.E., Ghoreishi, D., Gilson, M.K., Gohlke, H., Goetz, A.W., Greene, D., Harris, R., Homeyer, N., Huang, Y., Izadi, S., Kovalenko, A., Kurtzman, T., … & Kollman, P.A. (2018). AMBER 18. San Francisco: University of California.
   Google Scholar
• Chen, Y., Yiu, C.-P., & Wong, K.-Y. (2020). Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: Virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Research, 9, 129. https://doi.org/10.12688/f1000research.22457.2
   PubMedGoogle Scholar
• Dash, J. J., Purohit, P., & Meher, B. R. (2020). Binding interactions of JE-2147 (normal vs methylated) to HIV-1 protease: A molecular dynamics simulation study for drug design strategy. In Proceedings of International Conference on Drug Discovery (ICDD) 2020.
   Google Scholar
• Dewar, M. J. S., Zoebisch, E. G., Healy, E. F., & Stewart, J. P. (1985). Development and use of quantum mechanical molecular models. 76. AM1: A new general purpose quantum mechanical molecular model. Journal of the American Chemical Society, 107(13), 3902–3909. https://doi.org/10.1021/ja00299a024
   Web of Science ®Google Scholar
• Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. The Journal of Chemical Physics, 103(19), 8577–8593. https://doi.org/10.1063/1.470117
   Web of Science ®Google Scholar
• Fintelman-Rodrigues, N., Sacramento, C. Q., Lima, C. R., Souza da Silva, F., Ferreira, A. C., Mattos, M., de Freitas, C. S., Soares, V. C., da Silva Gomes Dias, S., Temerozo, J. R., Miranda, A. R., Matos, M. D., Bozza, F. A., Carels, N., Alves, C. R., Siqueira, M. M., Bozza Thiago Moreno, L., & Souza., P. T. (2020). Atazanavir, alone or in combination with Ritonavir, inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production. Antimicrobial Agents and Chemotherapy, 64(10), e00825-20. https://doi.org/10.1128/AAC.00825-20
   PubMed Web of Science ®Google Scholar
• Ghahremanpour, M. M., Tirado-Rives, J., Deshmukh, M., Ippolito, J. A., Zhang, C., Cabeza de Vaca, I., Liosi, M., Anderson, K. S., & Jorgensen, W. L. (2020). Identification of 14 known drugs as inhibitors of the main protease of SARS-CoV-2. ACS Medicinal Chemistry Letters, 11(12), 2526–2533. https://doi.org/10.1021/acsmedchemlett.0c00521
   PubMed Web of Science ®Google Scholar
• Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M. A., & Halim, M. A. (2021). A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 39(9), 3213–3224. https://doi.org/10.1080/07391102.2020.1761883
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., & Duan, Y. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582, 289–293. https://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Jorgensen, W., Chandrasekhar, J., Madura, J., Impey, R., & Klein, M. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935. https://doi.org/10.1063/1.445869
   Web of Science ®Google Scholar
• Joshi, T., Bhat, S., Pundir, H., & Chandra, S. (2021). Identification of Berbamine, Oxyacanthine and Rutin from Berberis asiatica as anti-SARS-CoV-2 compounds: An in silico study. Journal of Molecular Graphics & Modelling, 109, 108028. https://doi.org/10.1016/j.jmgm.2021.108028
   PubMed Web of Science ®Google Scholar
• Kageyama, S., Mimoto, T., Murakawa, Y., Nomizu, M., Ford, H., Shirasaka, T., Gulnik, S., Erickson, J., Takada, K., & Hayashi, H. (1993). In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine. Antimicrobial Agents and Chemotherapy, 37(4), 810–817. https://doi.org/10.1128/AAC.37.4.810
   PubMed Web of Science ®Google Scholar
• Kavitha, K., Sivakumar, S., & Ramesh, B. (2020). 1,2,4 Triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates. Biophysical Chemistry, 267, 106478. https://doi.org/10.1016/j.bpc.2020.106478
   PubMed Web of Science ®Google Scholar
• Keretsu, S., Bhujbal, S. P., & Cho, S. J. (2020). Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation. Scientific Reports, 10, 17716. https://doi.org/10.1038/s41598-020-74468-0
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand–protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778–2786. https://doi.org/10.1021/ci200227u
   PubMed Web of Science ®Google Scholar
• Lim, K. P., Ng, L. F. P., & Liu, D. X. (2000). Identification of a novel cleavage activity of the first papain-like proteinase domain encoded by open reading frame 1a of the coronavirus avian infectious bronchitis virus and characterization of the cleavage products. Journal of Virology, 74(4), 1674–1685. https://doi.org/10.1128/jvi.74.4.1674-1685.2000
   PubMed Web of Science ®Google Scholar
• Lu, I.-L., Mahindroo, N., Liang, P.-H., Peng, Y.-H., Kuo, C.-J., Tsai, K.-C., Hsieh, H.-P., Chao, Y.-S., & Wu, S.-Y. (2006). Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease. Journal of Medicinal Chemistry, 49(17), 5154–5161. https://doi.org/10.1021/jm060207o
   PubMed Web of Science ®Google Scholar
• Mahase, E. (2021). Covid-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ (Clinical Research Ed.), 375, n2713. https://doi.org/10.1136/bmj.n2713
   PubMed Web of Science ®Google Scholar
• Maier, J., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. https://doi.org/10.1021/acs.jctc.5b00255
   PubMed Web of Science ®Google Scholar
• Martinez, M. A. (2020). Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrobial Agents and Chemotherapy, 64(5), e00399-20. https://doi.org/10.1128/AAC.00399-20
   PubMed Web of Science ®Google Scholar
• Meher, B. R., Purohit, P., & Dash, J. J. (2020). Probing phytochemicals as prospective antiviral agents against HIV-1 protease through structure-based virtual screening and molecular dynamics simulations. In Proceedings of International Conference on Drug Discovery (ICDD) 2020.
   Google Scholar
• Meher, B. R., & Wang, Y. (2012a). Binding of single walled carbon nanotube to WT and mutant HIV-1 proteases: Analysis of flap dynamics and binding mechanism. Journal of Molecular Graphics and Modelling, 38, 430–445. https://doi.org/10.1016/j.jmgm.2012.10.001
   PubMed Web of Science ®Google Scholar
• Meher, B. R., & Wang, Y. (2012b). Interaction of I50V mutant and I50L/A71V double mutant to HIV-1 protease inhibitor TMC114 (Darunavir): Molecular dynamics and free energy studies. The Journal of Physical Chemistry B, 116(6), 1884–1900. https://doi.org/10.1021/jp2074804
   PubMed Web of Science ®Google Scholar
• Meher, B. R., & Wang, Y. (2015). Exploring the drug resistance of V32I and M46L mutant HIV-1 protease to inhibitor TMC114: Flap dynamics and binding free energy studies. Journal of Molecular Graphics and Modelling, 56, 60–73. https://doi.org/10.1016/j.jmgm.2014.11.003
   PubMed Web of Science ®Google Scholar
• Miller, B. R., III, McGee, T. D., Jr., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321. https://doi.org/10.1021/ct300418h
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). Autodock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Nukoolkarn, V., Lee, V. S., Malaisree, M., Aruksakulwong, O., & Hannongbua, S. (2008). Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors. Journal of Theoretical Biology, 254(4), 861–867. https://doi.org/10.1016/j.jtbi.2008.07.030
   PubMed Web of Science ®Google Scholar
• Onufriev, A., Bashford, D., & Case, D. A. (2000). Modification of the generalized Born model suitable for macromolecules. The Journal of Physical Chemistry B, 104(15), 3712–3720. https://doi.org/10.1021/jp994072s
   Web of Science ®Google Scholar
• Purohit, P., Dash, J. J., & Meher, B. R. (2020). Exploration of phytocompounds as potential anti-dengue agents against DENV NS2B/NS3 protease: Structure-based virtual screening and MD simulation studies. In Proceedings of International Conference on Drug Discovery (ICDD) 2020.
   Google Scholar
• Reddy, A. D., Suh, S. B., Ghaffari, R., Singh, N. J., Kim, D.-J., & Han, J. H. (2003). Bioinformatics analysis of SARS proteins and molecular dynamics simulated structure of an alpha-helix motif. Bulletin-Korean Chemical Society, 24, 899–900.
   Web of Science ®Google Scholar
• Reyaz, S., Tasneem, A., Prakash Rai, G., & Bairagya, H. (2021). Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study. Journal of Molecular Graphics & Modelling, 109, 108021. https://doi.org/10.1016/j.jmgm.2021.108021
   PubMed Web of Science ®Google Scholar
• Roe, D. R., & Cheatham, T. E., III. (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. https://doi.org/10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Ryckaert, J. P., Ciccotti, G., & Berendsen, H. J. C. (1977). Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. Journal of Computational Physics, 23(3), 327–341. https://doi.org/10.1016/0021-9991(77)90098-5
   Web of Science ®Google Scholar
• Sang, P., Tian, S. H., Meng, Z. H., & Yang, L. Q. (2020). Anti-HIV drug repurposing against SARS-CoV-2. RSC Advances, 10(27), 15775–15783. https://doi.org/10.1039/D0RA01899F
   PubMed Web of Science ®Google Scholar
• Sk, M. F., Roy, R., Jonniya, N. A., Poddar, S., & Kar, P. (2020). Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations. Journal of Biomolecular Structure and Dynamics, 0, 1–15.
   Google Scholar
• Swain, S., Singh, S., Sahoo, A., Hussain, T., & Pati, S. (2021). Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: A molecular docking-simulation base assessment. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2021.1885495
   Google Scholar
• Ton, A.‐T., Gentile, F., Hsing, M., Ban, F., & Cherkasov, A. (2020). Rapid identification of potential inhibitors of SARS‐CoV‐2 main protease by deep docking of 1.3 billion compounds. Molecular Informatics, 39(8), 2000028. https://doi.org/10.1002/minf.202000028
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. Journal of Computational Chemistry, 31(2), 455–461.
   PubMed Web of Science ®Google Scholar
• Wahedi, H. M., Ahmad, S., & Abbasi, S. W. (2020). Stilbene-based natural compounds as promising drug candidates against COVID-19. Journal of Biomolecular Structure and Dynamics, 39, 3225–3234. https://doi.org/10.1080/07391102.2020.1762743
   PubMed Web of Science ®Google Scholar
• Wang, J. (2020). Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study. Journal of Chemical Information & Modeling, 0, 0–0.
   Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174. https://doi.org/10.1002/jcc.20035
   PubMed Web of Science ®Google Scholar
• WHO (World Health Organization). www.who.int/dg/speeches/detail
   Google Scholar
• Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., Yuan, M.-L., Zhang, Y.-L., Dai, F.-H., Liu, Y., Wang, Q.-M., Zheng, J.-J., Xu, L., Holmes, E. C., & Zhang, Y.-Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265–269. https://doi.org/10.1038/s41586-020-2008-3
   PubMed Web of Science ®Google Scholar
• Xia, B., & Kang, X. (2011). Activation and maturation of SARS-CoV main protease. Protein & Cell, 2(4), 282–290. https://doi.org/10.1007/s13238-011-1034-1
   PubMed Web of Science ®Google Scholar
• Yamamoto, N., Yang, R., Yoshinaka, Y., Amari, S., Nakano, T., Cinatl, J., Rabenau, H., Doerr, H. W., Hunsmann, G., Otaka, A., Tamamura, H., Fujii, N., & Yamamoto, N. (2004). HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochemical and Biophysical Research Communications, 318(3), 719–725. https://doi.org/10.1016/j.bbrc.2004.04.083
   PubMed Web of Science ®Google Scholar
• Yoshimura, K., Kato, R., Yusa, K., Kavlick, M., Maroun, V., Nguyen, A., Mimoto, T., Ueno, T., Shintani, M., Falloon, J., Masur, H., Hayashi, H., Erickson, J., & Mitsuya, H. (1999). JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1. Proceedings of the National Academy of Sciences, 96(15), 8675–8680. https://doi.org/10.1073/pnas.96.15.8675
   PubMed Web of Science ®Google Scholar
• Zhang, X. W., & Yap, Y. L. (2004). Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs. Bioorganic & Medicinal Chemistry, 12(10), 2517–2521. https://doi.org/10.1016/j.bmc.2004.03.035
   PubMed Web of Science ®Google Scholar
• Zhou, P. X.-L., Yang, X.-G., Wang, B., Hu, L., Zhang, W., Zhang, H.-R., Si, Y., Zhu, B., Li, C.-L., Huang, H.-D., Chen, J., Chen, Y., Luo, H., Guo, R.-D., Jiang, M.-Q., Liu, Y., Chen, X.-R., Shen, X., Wang, X.-S., … Shi, Z.-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273. https://doi.org/10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar